These enzymes have been implicated in key cancer-associated processes such as extracellular matrix degradation (MMP14, plasmin), tumor invasion and metastasis (CATB), immune regulation and signaling (USP15), and cancer-related proteolytic processing (ACE2, METAP1/2). Here, USP15 is linked to cancer.